Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 28:2013:628073.
doi: 10.1155/2013/628073. eCollection 2013.

Cytotoxic and apoptotic effects of different extracts of Artemisia turanica Krasch. on K562 and HL-60 cell lines

Affiliations

Cytotoxic and apoptotic effects of different extracts of Artemisia turanica Krasch. on K562 and HL-60 cell lines

Zahra Tayarani-Najaran et al. ScientificWorldJournal. .

Abstract

Artemisia is an important genus of Iranian flora. Cytotoxic activities for some species of the genus have already been reported. In this study, we have investigated the cytotoxic effects of n-hexane, CH2Cl2, EtOAc, EtOH, and EtOH/H2O (1:1) extracts of A. turanica Krasch. on two human leukemic cancer cell lines (K562 and HL-60) and J774 as normal cells using alamarBlue (resazurin) assay. PI staining of the fragmented DNA and western blot analysis were used to evaluate the possible apoptotic effect of the extract. The CH2Cl2 extract of A. turanica showed the most antiproliferative effect on cancer cells among all tested extracts with IC50 values of 69 and 104 μ g/mL on K562 and HL-60 cells, respectively, whereas the normal cells were not affected significantly by this extract. Sub-G1 peak in the flow cytometry histogram of the cells treated with CH2Cl2 extract of A. turanica and cleavage of PARP protein confirmed the induction of apoptosis with CH2Cl2 extract. Taken together, the findings of the present work suggest the anticancer potential of CH2Cl2 extract of A. turanica on human leukemic cancer cell lines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Extraction scheme of n-hexane, CH2Cl2, EtOAc, EtOH, and EtOH/H2O (1 : 1) extracts of A. turanica.
Figure 2
Figure 2
The dose-dependent effects of n-hexane, CH2Cl2, EtOAc, EtOH, and EtOH/H2O (1 : 1) extracts on the growth of K562 and HL-60 cells and normal J774 cells. All extracts exhibited cytotoxic activity against apoptosis-proficient HL-60 and apoptosis-resistant K562 cells, with IC50 values ranging from 68.83 to >450 μg/mL and with much less cytotoxic effects on normal J774 cells. Values were mean ± SEM of at least three independent experiments, each in triplicates.
Figure 3
Figure 3
PI staining and flow cytometry analysis of CH2Cl2 extract (0, 25, 50, and 100 μg/mL) induced apoptosis in K562 and HL-60 cells.
Figure 4
Figure 4
Proteolytic cleavage of poly(ADP-ribose) polymerase (PARP) in HL-60 cells and level of Bax protein in HL-60 and K562 cells after 48 h exposure to CH2Cl2 extract of A. turanica (25, 50 and 100 μg/mL). β-Actin was used as a loading control. All Western blots were representative of 3 independent experiments.

Similar articles

Cited by

References

    1. Hsiao WLW, Liu L. The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights. Planta Medica. 2010;76(11):1118–1131. - PubMed
    1. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. International Journal of Oncology. 2001;18(4):767–773. - PubMed
    1. Choi E, Park H, Lee J, Kim G. Anticancer, antiobesity, and anti-inflammatory activity of Artemisia species in vitro . Journal of Traditional Chinese Medicine. 2013;33:92–97. - PubMed
    1. Taghizadeh Rabe SZ, Mahmoudi M, Ahi A, Emami SA. Antiproliferative effects of extracts from Iranian Artemisia species on cancer cell lines. Pharmaceutical Biology. 2011;49(9):962–969. - PubMed
    1. Tin AS, Sundar SN, Tran KQ, Park AH, Poindexter KM, Firestone GL. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes. Anti-Cancer Drugs. 2012;23(4):370–379. - PubMed

Publication types